A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism

Kidney International

Volumn 58, Issue 1, 2000, Pages 436-445

  Goodman, William G ^a,b   Frazao, Joao M ^a,b   Goodkin, David A ^a,b   Turner, Stewart A ^a,b   Liu, Wei ^a,b   Coburn, Jack W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMGEN INC   (United States)

Author keywords

Chronic renal disease; End stage renal disease; Hemodialysis; Parathyroid hormone; R 568

Indexed keywords

CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; DRUG; PARATHYROID HORMONE; R 568;

ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; KIDNEY FAILURE; MULTICENTER STUDY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY HYPERPARATHYROIDISM;

EID: 0033935152     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00183.x     Document Type: Article

References (30)

1. D.J. Sherrard G. Hercz Y. Pei N. Maloney C. Greenwood A. Manuel C. Saiphoo S.S. Fenton G.V. Segre The spectrum of bone disease in end-stage renal failure: An evolving disorder Kidney Int 43 1993 436 442
2. H. Malluche M.C. Faugere Renal bone disease 1990: An unmet challenge for the nephrologist Kidney Int 38 1990 193 211
3. I.B. Salusky W.G. Goodman Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy Kidney Int 48 1995 657 665
4. W.G. Goodman J.W. Coburn E. Slatopolsky I.B. Salusky Renal osteodystrophy in adult and pediatric patients, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (3rd ed) edited by FAVUS M 1996 Raven Press New York 341 360
5. I.B. Salusky R.N. Fine H. Kangarloo R. Gold L. Paunier W.G. Goodman J.E. Brill G. Gilli E. Slatopolsky J.W. Coburn “High-dose” calcitriol for control of renal osteodystrophy in children on CAPD Kidney Int 32 1987 89 95
6. L.D. Quarles G.A. Davidai S.J. Schwab D.W. Bartholomay B. Lobaugh Oral calcitriol and calcium: Efficient therapy for uremic hyperparathyroidism Kidney Int 34 1988 840 844
7. D.L. Andress K.C. Norris J.W. Coburn E.A. Slatopolsky D.J. Sherrard Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure N Engl J Med 321 1989 274 279
8. 2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients in hemodialysis J Am Soc Nephrol 9 1998 1427 1432
9. 2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism Kidney Int 51 1997 317 323
10. E.F. Nemeth Calcium receptors as novel drug targets, Principles in Bone Biology edited by Bilezikian JP, Raisz, LG, Rodan, GA 1996 Academic Press New York 1019 1035
11. M. Wada H. Ishii Y. Furuya J. Fox E.F. Nemeth N. Nagano NPS R-568 halts or reverses osteitis fibrosa in uremic rats Kidney Int 53 1998 448 453
12. +2 receptor-dependent regulation of cellular functions News Physiol Sci 10 1995 1 5
13. S.J. Silverberg Hg Bone III T.B. Marriott F.G. Locker S. Thys-Jacobs G. Dziem S. Kaatz E.L. Sanguinetti J.P. Bilezikian Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism N Engl J Med 337 1997 1506 1510
14. J.E. Antonsen D.J. Sherrard D.L. Andress A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure Kidney Int 53 1998 223 227
15. 3 J Biol Chem 263 1988 2203 2208
16. T. Okazaki J.D. Zajac T. Igarashi E. Ogata H.M. Kronenberg Negative regulatory elements in the human parathyroid hormone gene J Biol Chem 266 1991 21903 21910
17. J. Silver T. Naveh-Many H. Mayer H.J. Schmelzer M.M. Popovtzer Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat J Clin Invest 78 1986 1296 1301
18. T. Naveh-Many J. Silver Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression Endocrinology 133 1993 2724 2728
19. M.T. Collins M.C. Skarulis J.P. Bilezikian S.J. Silverberg A.M. Spiegel S.J. Marx Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent J Clin Endocrinol Metab 83 1998 1080 1083
20. S.F. Sena Gn Bowers Jr Measurement of ionized calcium in biological fluids: Ion-selective electrode method Methods Enzymol 158 1988 320 334
21. V.P. Michelangeli P. Heyma P.G. Colman P.R. Ebeling Evaluation of a new, rapid and automated immunochemiluminometric assay for the measurement of serum intact parathyroid hormone Ann Clin Biochem 34 1997 97 103
22. W.J. Dixon F.J. Massey Introduction to Statistical Analysis 4th ed 1983 McGraw-Hill Book New York
23. W.G. Goodman T. Belin B. Gales H. Jüppner G.V. Segre I.B. Salusky Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism Kidney Int 48 1995 1553 1558
24. W.G. Goodman J.D. Veldhuis T.R. Belin A.J. Van Herle H. Jüppner I.B. Salusky Calcium-sensing by parathyroid glands in secondary hyperparathyroidism J Clin Endocrinol Metab 83 1998 2765 2772
25. +2-sensing receptor in primary and uremic secondary hyperparathyroidism J Clin Endocrinol Metab 81 1996 1598 1606
26. J. Gogusev P. Duchambon B. Hory M. Giovannini Y. Goureau E. Sarfati T.B. Drüeke Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism Kidney Int 51 1997 328 336
27. +2 receptor from brain to gut: Common stimulus, diverse actions Trends Endocrinol Metab 9 1998 354 359
28. D. Riccardi J. Park W.S. Lee G. Gamba E.M. Brown S.C. Hebert Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor Proc Natl Acad Sci USA 92 1995 131 135
29. 2+ sensing J Clin Invest 96 1995 1582 1590
30. 2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells J Bone Miner Res 13 1998 1530 1538